CDK9-IN-31 (dimaleate)

CDK9-IN-31 dimaleate (Compound Z1) is a CDK9 inhibitor that inhibits cancer cell growth. CDK9-IN-31 dimaleate has the potential to be developed as an anticancer agent[1].

Product Specifications

UNSPSC

12352005

Target

CDK

Type

Reference compound

Related Pathways

Cell Cycle/DNA Damage

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/cdk9-in-31-dimaleate.html

Solubility

10 mM in DMSO

Smiles

O=C(O)/C=C\C(O)=O.OC[C@@H](C)N[C@@H](CC1)CC[C@H]1NC2=CC(C3=CSC(NCC4(CCOCC4)C#N)=N3)=C(Cl)C=N2.O=C(O)/C=C\C(O)=O

Molecular Formula

C32H41ClN6O10S

Molecular Weight

737.22

References & Citations

[1]Fusheng Zhou, et al. CDK9 inhibitor and preparation method and application thereof. Patent CN116496267A.

Shipping Conditions

Room temperature

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

NB100-351R 0.1 mL

Mouse Monoclonal RNase L Antibody (2E9) [DyLight 550]

Ask

View Details

MPR00545 150 µL / 10 µM

rno-miR-25-5p Primers

Ask

View Details

MBS9925794 Inquire

Chicken SH3 and Multiple Ankyrin Repeat Domains Protein 1 (SHANK1) ELISA Kit

Ask

View Details

TR304060 1 Kit

Homeo box C10 (HOXC10) Human shRNA Plasmid Kit (Locus ID 3226)

Ask

View Details

MBS1072348-01 0.02 mg (E-Coli)

Recombinant Enterobacteria phage P22 Holin (13)

Ask

View Details

MBS1072348-02 0.1 mg (E-Coli)

Recombinant Enterobacteria phage P22 Holin (13)

Ask

View Details